Tomoyuki Miyabayashi

Summary

Affiliation: Asahi Kasei Corporation
Country: Japan

Publications

  1. ncbi request reprint BET, a novel neuronal transmembrane protein with multiple EGF-like motifs
    Hirofumi Nishizumi
    Department of Biophysics, Central Technology Laboratory, Asahi Kasei Corporation, 2 1 Samejima, Fuji, Shizuoka 416 8501, Japan
    Neuroreport 13:909-15. 2002
  2. pmc Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency
    Tomoyuki Miyabayashi
    Central R and D Laboratories, Asahi Kasei Corporation, Shizuoka 416 8501, Japan
    Proc Natl Acad Sci U S A 104:5668-73. 2007
  3. ncbi request reprint Indole derivatives sustain embryonic stem cell self-renewal in long-term culture
    Tomoyuki Miyabayashi
    Central R and D Laboratories, Asahi Kasei Corporation, Fuji, Shizuoka 416 8501, Japan
    Biosci Biotechnol Biochem 72:1242-8. 2008

Collaborators

Detail Information

Publications3

  1. ncbi request reprint BET, a novel neuronal transmembrane protein with multiple EGF-like motifs
    Hirofumi Nishizumi
    Department of Biophysics, Central Technology Laboratory, Asahi Kasei Corporation, 2 1 Samejima, Fuji, Shizuoka 416 8501, Japan
    Neuroreport 13:909-15. 2002
    ..BET is the first transmembrane protein containing only multiple EGF-like repeats specifically expressed in the brain...
  2. pmc Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency
    Tomoyuki Miyabayashi
    Central R and D Laboratories, Asahi Kasei Corporation, Shizuoka 416 8501, Japan
    Proc Natl Acad Sci U S A 104:5668-73. 2007
    ..The increase in beta-catenin/CBP-mediated transcription at the expense of beta-catenin/p300-mediated transcription is critical for the maintenance of murine stem cell pluripotency...
  3. ncbi request reprint Indole derivatives sustain embryonic stem cell self-renewal in long-term culture
    Tomoyuki Miyabayashi
    Central R and D Laboratories, Asahi Kasei Corporation, Fuji, Shizuoka 416 8501, Japan
    Biosci Biotechnol Biochem 72:1242-8. 2008
    ..These results indicate that our compounds provide a more efficient and safer large-scale culture system for pluripotent ESCs, and hence might contribute to the use of ESCs in therapeutic applications...